# Zanamivir

## Relenza inhalation 5mg/dose (Government)

| 藥物代碼           | EREL                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of influenza A & B in adults & children >=5 year.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | Very rarely, allergic-type reactions, including oropharyngeal edema, bronchospasm, dyspnea, rash, urticaria.Central nervous system: Headache (prophylaxis 13% to 24%; treatment 2%)Respiratory: Cough (influenza prophylaxis in pediatric patients, 16% ), Nasal symptom (influenza prophylaxis in pediatric patients, 20% ), Pain in throat (influenza prophylaxis in pediatric patients, 11%), Respiratory depressionOther: Fever with chills (influenza prophylaxis, 5% ) |
| 禁忌               | Hypersensitivity to any of the ingredients of Relenza.                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 用法用量           | Adult & children >= 5 years 2 inhalations bid for 5 days, providing a total inhaled dose of 20 mg/day. Treatment should begin as soon as possible (preferably within 2 days) after onset of symptoms. Prophylaxis: (5 years or older) 10 mg (2 ORAL INHALATIONS) once a day for 7 to 10 days                                                                                                                                                                                 |
| 肝功能異常         | 無需調整劑量  需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常         | 無需調整劑量  需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 孕期用藥建議       | Compatible - maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 注射劑給藥建議途徑 | IH, INHL                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

